@FiercePharma: Stada exec says board would entertain the right offer. Report | Follow @FiercePharma
@AlisonBFierce: Manufacturers already shipped more than 128M doses of flu vaccine--nearly 95% of the 135M doses made this season. More | Follow @AlisonBFierce
> France is asking the European Medicines Agency to add labeling warnings to newer contraceptives over concerns of higher risks of blood clots. Story
> A report by Morgan Stanley says India's drug market could grow nearly 20% this year as early investments start to provide results. Item
> Canadian pharmacy chain Jean Coutu Group said sales of its generic drug line have lifted its quarterly profit 10%. Story
> Gilead Sciences ($GILD) is being criticized by HIV support groups for having moved prices up on a number of its most-used drugs. Story
@FierceMedDev: Bayer gains FDA nod for long-use IUD. Story | Follow @FierceMedDev
@MarkHFierce: A Swiss Dx company focused on nanotech brought in $3M in new Series A financing. Article | Follow @MarkHFierce
@DamianFierce: $LLY's jumping back on the companion diagnostics bandwagon with a new Dako partnership. Report | Follow @DamianFierce
> Medtronic hunts for expanded pacer indication with large study. Story
> As of July 1, Malaysia mandates device product registration. Item
Biotech News
@FierceBiotech: J&J's diabetes drug passes FDA panel test despite safety concerns. Story | Follow @FierceBiotech
@RyanMFierce: Another failure for tivantinib $ARQL. Ph2 in colon cancer after PhIII fiasco in lung cancer last year. | Follow @RyanMFierce
> GSK rests hopes on R&D pipeline after tough 2012. Article
> ArQule, Daiichi cough up another failure for lead cancer drug. Story
And Finally... A three-week direct-to-consumer campaign to boost confidence in generic drugs is kicking off in France where only about 25% of prescriptions are for generics, compared with about 80% in the U.S. Story